Back to Studies P1051 / Pharmacokinetic Study of Tipranavir with Ritonavir in HIV-infected Patients. A Multiple Dose, Open Label, Randomized, Safety and Pharmacokinetic Study of Tipranavir in Combination with Low Dose Ritonavir in HIV-Infected Pediatric Patients OverviewProtocol TeamPublications/Presentations Study Status Concluded DAIDS Number 10109 IND Number 51,979 Primary Protocol Team Members Katherine Luzuriaga Study Vice-Chair Ram Yogev Study Co-Chair Juan Carlos Salazar Study Co-Chair Loading study documents... Loading study sites... Loading study protocol team... Loading study press... Loading study publications/presentations...